Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H21NO3.ClH |
Molecular Weight | 335.825 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CC[C@@]23[C@H]4CCC(=O)[C@]2(C)OC5=C(O)C=CC(C[C@@H]14)=C35
InChI
InChIKey=IUIZPWPENLRTFZ-RNWHKREASA-N
InChI=1S/C18H21NO3.ClH/c1-17-14(21)6-4-11-12-9-10-3-5-13(20)16(22-17)15(10)18(11,17)7-8-19(12)2;/h3,5,11-12,20H,4,6-9H2,1-2H3;1H/t11-,12+,17-,18-;/m0./s1
Molecular Formula | C18H21NO3 |
Molecular Weight | 299.3642 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Metopon was developed as an analgesic opium derivative. This drug has a high affinity to the mu-opioid receptor and produces antinociception through this receptor. Metopon was available in Canada only in tablet form for oral administration; however, because of the drug addiction, the Drug Addiction Committee recommended its limited use.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18897557
Metopon will be available in Canada only in tablet form for oral administration. The tablets will be put up in bottles of 50 and each tablet will contain 8.0 mgm. of metopon hydrochloride.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:22 GMT 2025
by
admin
on
Mon Mar 31 17:34:22 GMT 2025
|
Record UNII |
6O34Q1K8M6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9260
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110992
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
124-92-5
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
m7497
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID10154184
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
C83964
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
C046877
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
6O34Q1K8M6
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
16057830
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |